PHRM hits 52-week high at 71.66 -
Pharmion Corp (PHRM) Corporate Event Announcement Notice -
PHRM hits 52-week high at 71.51 -
ISS Recommends Pharmion Shareholders Vote For Merger With Celgene - Update -
Pharmion Says ISS Recommends Company Shareholders Vote For Merger With Celgene -
Pharmion Corp (PHRM) Corporate Event Announcement Notice -
Pharmion Corp (PHRM) Corporate Event Announcement Notice -
Pharmion Corp (PHRM) Corporate Event Announcement Notice -
Pharmion Q4 Net Loss Narrows -
Pharmion Q4 Loss Narrows - Quick Facts -
Pharmion Reports December Quarter Loss Of $0.74 Per Share -
Pharmion Corporation Announces 2007 Operating Results -
RealPennies.com: RealPennies.com: Turning Pennies into dollars: (NASDAQ: PHRM) -
Pharmion, MethylGene leukemia drug granted orphan drug status by FDA -
Market Review: Global Market Progressive Review for Pharmion -
The Maybach Journal: Has added Pharmion Corp. to their watch list -